A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Qurient Co., Ltd.
Takeda
Coherus Oncology, Inc.
Bayer
Intensity Therapeutics, Inc.
Celldex Therapeutics
Bayer
Xencor, Inc.
MultiVir, Inc.